Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 30, 2024 (Week 48)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 76 NC 4,351 6,358
New England 1 NC 72 102
Connecticut - NC - -
Maine 1 NC 24 43
Massachusetts - NC - -
New Hampshire - NC 15 25
Rhode Island - NC 32 31
Vermont - NC 1 3
Middle Atlantic 1 NC 150 537
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 235
Pennsylvania 1 NC 150 302
East North Central 49 NC 2,018 2,612
Illinois - NC 51 674
Indiana - NC 236 375
Michigan - NC 196 319
Ohio 49 NC 1,402 1,200
Wisconsin - NC 133 44
West North Central - NC 146 257
Iowa - NC 57 83
Kansas - NC 81 81
Minnesota - NC - 75
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC - 12
South Dakota - NC 8 6
South Atlantic 16 NC 585 801
Delaware - NC 15 12
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 289
Maryland - NC - -
North Carolina - NC - 169
South Carolina - NC - -
Virginia 16 NC 462 245
West Virginia - NC 108 86
East South Central - NC 94 211
Alabama N NC N N
Kentucky - NC - -
Mississippi - NC 94 211
Tennessee - NC - -
West South Central - NC - 24
Arkansas - NC - -
Louisiana - NC - 24
Oklahoma - NC - -
Texas U NC U U
Mountain 9 NC 1,266 949
Arizona 9 NC 1,161 786
Colorado - NC - -
Idaho - NC - -
Montana - NC 8 1
Nevada - NC 2 95
New Mexico - NC 52 -
Utah - NC 43 66
Wyoming - NC - 1
Pacific - NC 20 865
Alaska - NC - -
California - NC - 740
Hawaii - NC - 21
Oregon - NC 20 26
Washington - NC - 78
U.S. Territories - NC 1 167
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC 1 -
Puerto Rico - NC - 167
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 2 1
Total 76 NC 4,354 6,526
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.